Correlation Between Inovio Pharmaceuticals and Co Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Co Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Co Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Co Diagnostics, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Co Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Co Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Co Diagnostics.

Diversification Opportunities for Inovio Pharmaceuticals and Co Diagnostics

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Inovio and CODX is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Co Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Co Diagnostics and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Co Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Co Diagnostics has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Co Diagnostics go up and down completely randomly.

Pair Corralation between Inovio Pharmaceuticals and Co Diagnostics

Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to under-perform the Co Diagnostics. In addition to that, Inovio Pharmaceuticals is 1.11 times more volatile than Co Diagnostics. It trades about -0.14 of its total potential returns per unit of risk. Co Diagnostics is currently generating about -0.12 per unit of volatility. If you would invest  89.00  in Co Diagnostics on November 28, 2024 and sell it today you would lose (38.00) from holding Co Diagnostics or give up 42.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inovio Pharmaceuticals  vs.  Co Diagnostics

 Performance 
       Timeline  
Inovio Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Co Diagnostics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Co Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Inovio Pharmaceuticals and Co Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inovio Pharmaceuticals and Co Diagnostics

The main advantage of trading using opposite Inovio Pharmaceuticals and Co Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Co Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Co Diagnostics will offset losses from the drop in Co Diagnostics' long position.
The idea behind Inovio Pharmaceuticals and Co Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Managers
Screen money managers from public funds and ETFs managed around the world